rediff.com
X   
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Marksans Pharma Ltd. - Research Center
524404 MARKSANS Group (B) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Annual results in brief
(Rs crore)
Mar ' 15 Mar ' 14 Mar ' 13 Mar ' 12 Mar ' 11
Sales 408.68 318.26 196.47 156.55 157.12
Operating profit 118.83 87.13 48.44 -153.04 -12.32
Interest 13.11 15.21 10.13 11.88 105.77
Gross profit 105.72 71.92 38.31 -164.92 -118.08
EPS (Rs) 1.64 1.44 1.03 -4.92 -5.92
Annual  results in details
Mar ' 15 Mar ' 14 Mar ' 13 Mar ' 12 Mar ' 11
Other income - - - - -
Stock adjustment 1.36 -1.84 9.19 10.33 0.04
Raw material 193.56 142.63 65.96 60.50 107.28
Power and fuel - - - - -
Employee expenses 23.66 21.39 15.39 13.55 11.38
Excise - - - - -
Admin and selling expenses - - - - -
Research and development expenses - - - - -
Expenses capitalised - - - - -
Other expenses 71.28 68.95 57.48 225.20 50.74
Provisions made - - - - -
Depreciation 9.03 8.66 8.70 17.98 14.64
Taxation 29.58 7.70 -9.98 -1.84 4.85
Net profit / loss 67.11 55.56 39.58 -181.07 -217.79
Extra ordinary item - - - - -80.22
Prior year adjustments - - - - -
Equity capital 40.93 38.53 38.53 36.78 36.78
Equity dividend rate - - - - -
Agg.of non-prom. shares (Lacs) 2118.22 1878.15 1886.34 1898.24 1898.24
Agg.of non promotoholding (%) 51.75 48.75 48.96 51.61 51.61
OPM (%) 29.08 27.38 24.66 -97.76 -7.84
GPM (%) - - - - -
NPM (%) - - - - -
Close
Add Marksans Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Marksans Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close